Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Liraglutide for Sale > Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - large image1
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image1
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image2
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image3
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image4
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image5
Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS buy - image6

Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS

30 Inquiries

Unit Price: Get Latest Price
CAS No.:

204656-20-2

Grade:

Top Product

Content:

98%

Port:

shanghai

Brand:

COMINGS

Packaging:

1KG per foil bag, 25KG per drum.

Price valid (until):

2025-06-26

Company Type:
Trader
Location:
China
Qualification:
Main Products:

semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    CAS:  204656-20-2
    Name:  Liraglutide
    Synonyms Name:  GLP-1
    Molecular formula:  C172H265N43O51
    Molecular Weight:  3751.20000
    Color white


      Product Detail  


    • What Is The Usage Of Liraglutide ?

      Suitable for adults with type 2 diabetes to control blood sugar:

      It is suitable for use in combination with metformin or sulfonylureas in patients whose blood sugar is still poorly controlled after treatment with the maximum tolerated dose of metformin or sulfonylureas alone.

      Indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes and cardiovascular disease. Suitable for adult patients who require long-term weight management as an auxiliary treatment to a low-calorie diet and increased exercise:

      Adult patients have an initial body mass index (BMI) of ≥30kg/m2 (obesity) [3]

      ≥27kg/m2 (overweight) with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or dyslipidemia)


      The Dosage Of Liraglutide Injection

      1. Blood sugar control in adults with type 2 diabetes:
      To improve gastrointestinal tolerability, the starting dose of liraglutide is 0.6 mg daily. After at least 1 week, the dose should be increased to 1.2 mg. It is expected that some patients will benefit from increasing the dose from 1.2 mg to 1.8 mg, and based on clinical response, the dose may be increased to 1.8 mg after at least one week to further improve the hypoglycemic effect. The recommended daily dose is not to exceed 1.8mg.
      This product can be used in combination therapy with metformin without changing the dose of metformin.
      This product can be used for combined treatment with sulfonylureas. When this product is used concomitantly with a sulfonylurea, a dose reduction of the sulfonylurea should be considered to reduce the risk of hypoglycemia.
      Blood glucose monitoring is not required when adjusting the dose of this product. However, blood glucose monitoring may be necessary when the dose of the sulfonylurea is adjusted when this product is used concomitantly with a sulfonylurea.
      2. Long-term weight management:
      The initial dose of liraglutide is 0.6 mg daily for 1 week, and should be used according to the dose escalation schedule in Table 1 to minimize gastrointestinal adverse effects. The recommended dose of this product is 3.0 mg daily.


      The Packaging Of Liraglutide

      1g,50g,100g,1000g

    Wuhan Comings Biotechnology Co., Ltd. was established in 2016. Since its establishment, the company has always been committed to making more people healthy, making more people young and happy, and providing customers with high-quality and efficient services.

    The company cooperates with biological experts from many universities, adopts modern gene cloning technology and unique purification technology, and strictly controls all aspects. The adipotide we produce are sold well in Europe, Africa, and America, and many customers have given good reviews.

    And our company has storage bases in Shenzhen, Shanghai, Qingdao ports to ensure that all goods can arrive safely, on time and quickly.

    Wuhan Comings Biotechnology Co., Ltd. is looking forward to cooperating with you with professional knowledge, high-quality service and competitive price!

    Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 1

    Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 2Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 3Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 4Shop JBSNF-000088/-Methoxynicotinamide 98% Powder 7150-23-4 COMINGS-Detailed Image 5

    Shop Weight Loss GLP-1 Injection Peptide 99% Purity Tirzepatide(LY3298176) Semaglutide/COMINGS-Detailed Image 6

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332

    Location:

    No. 1, 19th Floor, Unit 2, Building 5, Southeast Residential Building (Hankou Yujiang Lanting), at the intersection of Hanshi Highway and Fufa South Road, Wuhu Street, Huangpi District, Wuhan City, Hu

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    15

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2023

    We prospectively allocates international cutting-edge production and testing equipment and environmental protection facilities. The 5 production lines can achieve an annual output of 1000Kg. We to be the best chemical manufacture in China,and will become a trustworthy supplier of chemicals for global customers.
    Our main products include peptides, cognitive enhancers, pharmaceutical intermediates, and botanical extracts.
    And our main clients cover: pharmaceutical companies, hospitals, laboratories in higher education institutions, and cosmetic companies.
    Since its establishment, our company's products have been exported to regions including Europe, the Americas, the Middle East and so on. Our commitment to high product quality and excellent after-sales service has provided customers with a positive experience.
    Wuhan Comings Biotechnology Co., Ltd. is looking forward to cooperating with you with professional knowledge, high-quality service and competitive price!
  • Inquiry History
    30 Inquiries
    Country Product Purchase Quantity Date Posted
    Turkey

    CAS 204656-20-2 Liraglutide White Powder High Activity

    100 G Jun 7, 2023
    India

    Liraglutide CAS 204656-20-2 Blood Sugar Regulating Drug with Best Price

    1 KG Jun 19, 2023
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    United States

    Peptide Liraglutide/Victoza/Liraglutida 98% Powder 67-51-6 Weight Loss Senwayer

    1 KG Sep 30, 2023
    Jordan

    Liraglutide

    1.00 MT Sep 19, 2023
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.